Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Gamified Dual-Task Training for Balance and Exercise Enjoyment in Children With Spastic Cerebral Palsy

11 de noviembre de 2026 actualizado por: Doç.Dr.Ömer Şevgin, Uskudar University

Effects of Low-Cost Gamified Motor-Cognitive Dual-Task Training on Balance and Exercise Enjoyment in Ambulatory Children and Adolescents With Spastic Cerebral Palsy Aged 11-17 Years: A Randomized Controlled Trial

This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.

Descripción general del estudio

Descripción detallada

Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.

Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.

Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.

Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.

Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.

Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p < 0.05.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Güngören
      • Istanbul, Güngören, Turquía (Türkiye)
        • Bizim Çocuklarımız SPECIAL EDUCATION AND REHABILITATION CENTER
        • Contacto:
          • Amin Danesfhar

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

11 años a 17 años (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age 11-17 years
  • Diagnosis of spastic (unilateral or bilateral) cerebral palsy confirmed by a pediatric neurologist
  • Gross Motor Function Classification System (GMFCS) level I, II or III
  • Ability to walk independently for at least 10 meters with or without an assistive device
  • Ability to understand and follow two-step verbal commands
  • Receiving physiotherapy at the study center twice a week for at least 3 months
  • Written informed consent from the parent/legal guardian and written assent from the participant

Exclusion Criteria:

  • Botulinum toxin injection to the lower extremities within the last 6 months
  • Orthopedic surgery within the last 6 months
  • Uncontrolled epilepsy
  • Uncorrected visual or hearing impairment
  • Severe intellectual disability preventing performance of the cognitive tasks (counting, color discrimination)
  • Participation in another structured balance or exercise program during the study period
  • Uncontrolled cardiac or respiratory disease precluding exercise

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Gamified motor-cognitive dual-task training

Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment.

Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

Comparador activo: Standard single-task balance training

Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pediatric Balance Scale (PBS) score at 12 weeks
Periodo de tiempo: Week 12 (end of intervention)

The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy.

Week 12 (end of intervention)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Pediatric Balance Scale (PBS) score
Periodo de tiempo: Baseline, Week 12, Week 16 (4-week follow-up)

Same scale as the primary outcome; change from baseline.

Baseline, Week 12, Week 16 (4-week follow-up)
Timed Up and Go (TUG) test - single task
Periodo de tiempo: Baseline, Week 12, Week 16

Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility.

Baseline, Week 12, Week 16
Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)
Periodo de tiempo: Baseline, Week 12, Week 16

13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated.

Baseline, Week 12, Week 16
1-Minute Walk Test (1MWT)
Periodo de tiempo: Baseline, Week 12, Week 16

Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity.

Baseline, Week 12, Week 16
Physical Activity Enjoyment Scale (PACES-8, Turkish version)
Periodo de tiempo: Baseline, Week 12, Week 16

8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity.

Baseline, Week 12, Week 16

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Silla de estudio: Amin Danesfhar, Üsküdar University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de diciembre de 2026

Finalización primaria (Estimado)

20 de febrero de 2027

Finalización del estudio (Estimado)

20 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

11 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir